FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 89 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,247,000 | +242.1% | 513,629 | +18.1% | 0.01% | +200.0% |
| Q2 2022 | $2,995,000 | +49.7% | 434,744 | +102.1% | 0.00% | +100.0% |
| Q1 2022 | $2,001,000 | +171.9% | 215,141 | +315.5% | 0.00% | – |
| Q4 2021 | $736,000 | -67.1% | 51,776 | -46.3% | 0.00% | -100.0% |
| Q3 2021 | $2,236,000 | -7.0% | 96,425 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $2,404,000 | -42.8% | 96,586 | -35.7% | 0.00% | -50.0% |
| Q1 2021 | $4,206,000 | -39.8% | 150,140 | -25.1% | 0.00% | -60.0% |
| Q4 2020 | $6,991,000 | -52.3% | 200,328 | -36.4% | 0.01% | -75.0% |
| Q2 2020 | $14,645,000 | – | 315,006 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |